PROS1 and COVID-19: We focused on S protein capacity for modulating the production of two COVID-19-relevant, pro-inflammatory cytokines such as Interleukin-6 (IL-6) and Interferon-γ (IFN-γ) [4,5] in both primary and secondary immune responses, including those to polyclonal, mitogenic activators.